BRIEF published on 11/14/2025 at 15:35, 4 months 11 days ago Grünenthal Expands Bond Offering by €175 Million Financial Results Pharmaceutical Debt Issuance Grünenthal Bond Extension
PRESS RELEASE published on 11/14/2025 at 15:30, 4 months 11 days ago Grünenthal announces pricing of bond extension Grünenthal extends Senior Secured Notes by €175 million to a total of €675 million with 4.625% interest rate and maturity in 2031 Pharmaceutical Company Senior Secured Notes Grünenthal Debt Issue Bond Extension
BRIEF published on 03/27/2025 at 09:36, 11 months 30 days ago Grünenthal Reports Strong 2024 Financial Results Financial Results Strategic Growth US Market Expansion Grünenthal 2024 Valinor Acquisition
PRESS RELEASE published on 03/27/2025 at 09:31, 11 months 30 days ago Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal reports exceptional 2024 financial results driven by strategic growth and Valinor acquisition in the US Financial Results 2024 Strategic Growth Grünenthal Valinor Acquisition
BRIEF published on 12/06/2024 at 13:22, 1 year 3 months ago Grünenthal Successfully Issues €500 Million Bond Bond Issuance Grünenthal Maturity Profile €500 Million Finance Strategy
PRESS RELEASE published on 12/06/2024 at 13:17, 1 year 3 months ago Grünenthal successfully places new €500 million bond Grünenthal GmbH successfully places new €500 million bond to strengthen capital structure and pursue growth strategy, enhancing flexibility for investments and innovation Growth Strategy Bond Capital Structure Debt Issue Grünenthal GmbH
BRIEF published on 11/27/2024 at 09:40, 1 year 3 months ago Grünenthal Announces €500 Million Bond Pricing Bond Issuance Credit Ratings Debt Refinancing €500 Million Grünenthal GmbH
PRESS RELEASE published on 11/27/2024 at 09:35, 1 year 3 months ago Grünenthal announces pricing of €500 million bond Grünenthal GmbH announces pricing of €500 million bond to enhance capital structure and maturity profile. New financing to refinance existing debt and repurchase outstanding notes Bond Finance Debt Pricing Grünenthal GmbH
BRIEF published on 03/25/2024 at 09:35, 2 years ago Grünenthal Announces Strong Financial Results for 2023 with Continued Focus on R&D and Strategic Acquisitions Pharmaceuticals Annual Results Strategic Acquisitions Grünenthal R&D Investment
PRESS RELEASE published on 03/25/2024 at 09:30, 2 years ago Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Acquisitions 2023 Results Record Revenue R&D Investments Grünenthal
Published on 03/26/2026 at 13:00, 29 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 29 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 30 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 44 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 44 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 13:00, 29 minutes ago Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 44 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 1 hour 8 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 1 hour 12 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 07:30, 5 hours 59 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 18 hours 58 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 19 hours 44 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
